Join the Allergies group to help and get support from people like you.
Allergies News (Page 4)
Related terms: Allergy, Dust Mite Allergy
FDA Approves First Nasal Spray, Neffy, to Curb Anaphylaxis, An Alternative to Injections
FRIDAY, Aug. 9, 2024 – People who are nervous about administering a rescue shot for anaphylaxis finally have a new alternative in a nasal spray. The U.S. Food and Drug Administration on Friday...
FDA Approves First Nasal Spray, Neffy, to Curb Anaphylaxis, An Alternative to Injections
FRIDAY, Aug. 9, 2024 – People who are nervous about administering a rescue shot for anaphylaxis finally have a new alternative in a nasal spray. The U.S. Food and Drug Administration on Friday...
FDA Approves First Nasal Spray, Neffy, to Curb Anaphylaxis, An Alternative to Injections
FRIDAY, Aug. 9, 2024 – People who are nervous about administering a rescue shot for anaphylaxis finally have a new alternative in a nasal spray. The U.S. Food and Drug Administration on Friday...
Certain Pollens Worse for Triggering Asthma Attacks
FRIDAY, Aug. 9, 2024 – Pollen is a known trigger for seasonal allergies and asthma, but new research suggests that certain plant species release pollen that are especially tough on asthmatics....
Back-to-School Tips to Helping Your Kids Breathe Easier
SATURDAY, Aug. 3, 2024 – As kids and teens prepare to head back to school, parents might not have protecting their child's lung health on the top of their to-do lists. But experts say it should be....
Athletes Can Expect High Ozone, Pollen Counts for Paris Olympics
FRIDAY, July 26, 2024 – Bad news for Olympians headed to Paris – high levels of ozone pollution and grass pollen are likely during the upcoming games if hot, sunny weather prevails, researchers...
Allergy-Related Psychological Distress Common
TUESDAY, July 2, 2024 – Psychological distress related to food allergies (FA) is common globally, according to a study published online June 21 in Allergy. Rebecca C. Knibb, Ph.D., from Aston ...
U.S. FDA Approves ALK's Odactra (House Dust Mite Allergen Extract) Tablet for Sublingual Use as Immunotherapy for Adolescents
Odactra is now indicated to treat house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis, in persons 12 through 17 years of age, in addition to adults 18 through 65 years of...
FDA Medwatch Alert: FDA Alerts Patients and Health Care Professionals that Some EpiPen Auto-Injectors May Not Readily Slide Out of Carrier Tube
[11/2/2018] FDA is alerting patients, caregivers and health care professionals that the labels attached to some EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions,...
Adamis Pharmaceuticals Receives FDA Approval for Its Lower Dose Symjepi Product
SAN DIEGO, Sept. 27, 2018 (GLOBE NEWSWIRE) – Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) today announced that the U.S. Food and Drug Administration (“FDA”) has approved Adamis’ lower...
FDA Approves Odactra for House Dust Mite Allergies
March 1, 2017 – The U.S. Food and Drug Administration today approved Odactra, the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite (HDM)-induced...
Sanofi's Xyzal Allergy 24HR Approved for Over-the-Counter Use
BRIDGEWATER, N.J., Feb. 1, 2017 /PRNewswire/ – Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Xyzal Allergy 24HR as an over-the-counter (OTC) treatment for the...
FDA Approves Flonase Sensimist Allergy Relief
WARREN, N.J. 2 August 2016 – GSK Consumer Healthcare announced today that the U.S. Food and Drug Administration (FDA) has approved Flonase® Sensimist™ Allergy Relief (fluticasone furoate, 27.5 mcg sp...
FDA Medwatch Alert: Auvi-Q (epinephrine injection, USP): Recall - Potential Inaccurate Dosage Delivery
ISSUE: Sanofi US is voluntarily recalling all Auvi-Q (epinephrine injection, USP). The recall involves all Auvi-Q currently on the market and includes both the 0.15 mg and 0.3 mg strengths for...
FDA Approves Flonase Allergy Relief for Sale Over-the-Counter in the United States
London UK & Parsippany, US - Thursday 24 July 2014, GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Flonase Allergy Relief...
Further information
Related condition support groups
Hay Fever, Allergic Rhinitis, Allergic Reactions
Related drug support groups
prednisone, Benadryl, hydroxyzine, methylprednisolone, triamcinolone, Zyrtec, diphenhydramine, Allegra, loratadine, view more... promethazine, cetirizine, prednisolone, Vistaril, pseudoephedrine, Phenergan, dexamethasone, phenylephrine, fexofenadine, Atarax, epinephrine, montelukast, cyproheptadine, desonide